Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease

Détails

ID Serval
serval:BIB_1945CBE6F759
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease
Périodique
Circulation
Auteur⸱e⸱s
Pruvot  E., Thonet  G., Vesin  J. M., van-Melle  G., Seidl  K., Schmidinger  H., Brachmann  J., Jung  W., Hoffmann  E., Tavernier  R., Block  M., Podczeck  A., Fromer  M.
ISSN
1524-4539 (Electronic)
Statut éditorial
Publié
Date de publication
05/2000
Volume
101
Numéro
20
Pages
2398-404
Notes
Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't --- Old month value: May 23
Résumé
BACKGROUND: The recent availability of implantable cardioverter-defibrillators (ICDs) that record 1024 R-R intervals preceding a ventricular tachyarrhythmia (VTA) provides a unique opportunity to analyze heart rate variability (HRV) before the onset of VTA. METHODS AND RESULTS: Fifty-eight post-myocardial infarction patients with an implanted ICD for recurrent VTA provided 2 sets of 98 heart rate recordings in sinus rhythm: (1) before a VTA and (2) during control conditions. Three subgroups were considered according to the antiarrhythmic (AA) drug regimen. A state of sympathoexcitation was suggested by the significant reduction in HRV before VTA onset compared with control conditions. beta-Blockers and dl-sotalol enhanced HRV in control recordings; nevertheless, HRV declined before VTA independent of AA drugs. A gradual increase in heart rate and decrease in sinus arrhythmia at VTA onset were specific findings of patients who received dl-sotalol. CONCLUSIONS: The peculiar heart rate dynamics observed before VTA onset are suggestive of a state of sympathoexcitation that is independent of AA drugs.
Mots-clé
Adrenergic beta-Antagonists/therapeutic use Aged Anti-Arrhythmia Agents/therapeutic use Coronary Disease/*complications *Defibrillators, Implantable *Heart Rate/drug effects Humans Middle Aged Sotalol/therapeutic use Tachycardia, Ventricular/drug therapy/etiology/*physiopathology/*therapy
Pubmed
Web of science
Création de la notice
28/01/2008 10:04
Dernière modification de la notice
20/08/2019 12:50
Données d'usage